Home
| Support Units
| Clinical trials
| AN OPEN-LABEL STUDY OF THE SAFETY, TOLERABILLITY, AND PHARMACOKINETIC PROFILE OF M4344 (FORMERLY VX-803) as a single AGENT AND IN COMBINATION WITH CYTOTOXIC CHEMOTHERAPY IN PARTIPANTS WITH ADVANCED SOLID TUMORS

AN OPEN-LABEL STUDY OF THE SAFETY, TOLERABILLITY, AND PHARMACOKINETIC PROFILE OF M4344 (FORMERLY VX-803) as a single AGENT AND IN COMBINATION WITH CYTOTOXIC CHEMOTHERAPY IN PARTIPANTS WITH ADVANCED SOLID TUMORS

2014-003838-86CANCERFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR

Hospital Universitario Fundación Jiménez Díaz

Fundación Jiménez Díaz

Avda. Reyes Católicos, 2
28040 Madrid

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

C/ del Maestro Ángel Llorca, 6. Bajo B. Edificio alto. 28003-Madrid (España)
28015 Madrid

Instituto de Investigación Sanitaria acreditado por el Instituto de Salud Carlos III